<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="HLA-C allotypes interactions with KIR on dNK cells" Data-Source="WikiPathways" Version="WP5580_r141495" Author="[Johidi2, DeSl, Egonw, Eweitz]" Last-Modified="20251116023003" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">In decidual NK (dNK) cells, killer-cell immunoglobulin-like receptors (KIRs) interact with HLA-C allotypes on extravillous trophoblast (EVT) cells to modulate immune responses at the maternal–fetal interface. Inhibitory KIRs transmit signals through immunoreceptor tyrosine-based inhibitory motifs (ITIMs), which recruit SHP-1 and SHP-2 phosphatases to suppress activation pathways. Conversely, activating KIRs signal via the adaptor protein DAP12, whose ITAM motifs recruit SYK kinase, leading to downstream activation of LAT, SLP-76, VAV1, PLC-γ1, and NF-κB. This cascade promotes cytokine production and functional activation of dNK cells.
Additionally, KIR signaling has been linked to repeated pregnancy loss (RPL), suggesting coordination between immune signaling and placental development mediated by dNK cells. The exact origin of dNK cells (phenotype CD56⁺⁺ (bright) CD16⁻) is still uncertain. Some studies suggest they may arise from CD34⁺ progenitor cells, while others propose that peripheral blood NK (pbNK) cells or local NK precursors give rise to uterine NK (uNK) cells. These uNK cells may then differentiate into either endometrial NK (eNK) cells, which are present before pregnancy, or decidual NK (dNK) cells, which appear during early pregnancy.</Comment>
  <Graphics BoardWidth="2376.0" BoardHeight="1268.3191489361682" />
  <DataNode TextLabel="uNK cell" GraphId="a1f2d">
    <Comment>Uterine natural killer cell. A natural killer cell that is part of the uterus, specifically within the endometrium during the non-pregnant state and in the decidua during pregnancy. This cell exhibits dynamic changes in frequency throughout the menstrual cycle, with lower levels during menstruation and a significant increase during the mid-secretory phase and early pregnancy.</Comment>
    <Comment>Cell type ontology: CL:4052028</Comment>
    <Graphics CenterX="449.617915251206" CenterY="396.9072054353635" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="" ID="" />
  </DataNode>
  <DataNode TextLabel="HLA-C" GraphId="a47bc" Type="Protein">
    <Graphics CenterX="1666.819675431258" CenterY="260.57752640218024" Width="93.03493449781669" Height="27.056040756914175" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P10321" />
  </DataNode>
  <DataNode TextLabel="GM-CSF" GraphId="a77ee" Type="Protein" GroupRef="e4b79">
    <Comment>Enhances trophoblast motility</Comment>
    <Comment>Transwell assays with conditioned media

</Comment>
    <BiopaxRef>dd8</BiopaxRef>
    <Graphics CenterX="2043.0212765957467" CenterY="1179.6382978723377" Width="60.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P04141" />
  </DataNode>
  <DataNode TextLabel="DAG" GraphId="a7d6d" Type="Protein">
    <Graphics CenterX="2158.687943262415" CenterY="721.9716312056738" Width="60.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P17252" />
  </DataNode>
  <DataNode TextLabel="SLP-76" GraphId="a8080" Type="Protein">
    <Graphics CenterX="1550.354609929079" CenterY="683.9716312056739" Width="60.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q13094" />
  </DataNode>
  <DataNode TextLabel="IFN-γ" GraphId="a97ea" Type="Protein" GroupRef="e4b79">
    <Comment>Robustly produced following activating KIR engagement. </Comment>
    <Comment>IFN-γ inhibits trophoblast invasion by inducing apoptosis and suppressing protease activity</Comment>
    <Comment>Transcriptome profiling via microarray

</Comment>
    <BiopaxRef>df7</BiopaxRef>
    <BiopaxRef>a0c</BiopaxRef>
    <Graphics CenterX="2043.0212765957467" CenterY="1219.6382978723377" Width="60.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P01579" />
  </DataNode>
  <DataNode TextLabel="eNK cell" GraphId="a98b8">
    <Comment>Endometrial natural killer cell. ​​A uterine natural killer subset that is present in the endometrial lining during the non-pregnant state</Comment>
    <Comment>Cell type ontology: CL:4052051</Comment>
    <Graphics CenterX="680.9288396209558" CenterY="758.6298945109924" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="" ID="" />
  </DataNode>
  <DataNode TextLabel="VEGF-A" GraphId="aad35" Type="Pathway">
    <Comment>Supports trophoblast growth and vascular remodeling</Comment>
    <Graphics CenterX="1605.3546099290822" CenterY="1173.9716312056696" Width="60.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="WikiPathways" ID="WP3888" />
  </DataNode>
  <DataNode TextLabel="HLA-C" GraphId="b3802" Type="Protein">
    <Graphics CenterX="1395.671035672408" CenterY="262.1749125741872" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P10321" />
  </DataNode>
  <DataNode TextLabel="Syk" GraphId="b46a5" Type="Protein">
    <Graphics CenterX="1890.419474807723" CenterY="498.55029628162794" Width="60.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P43405" />
  </DataNode>
  <DataNode TextLabel="NLRP2" GraphId="b4c30" Type="Protein">
    <Comment>Expression: Differentially expressed (significant)
Measurement: RNA-seq
Role: upstream regulator of HLA-C
Source: GSE241792 (ELF3/NLRP7 KO vs WT)
</Comment>
    <Graphics CenterX="1596.9999999999984" CenterY="129.66666666666637" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q9NX02" />
  </DataNode>
  <DataNode TextLabel="MAPK Pathway" GraphId="b6ee0" Type="Pathway">
    <Graphics CenterX="1172.0639497971465" CenterY="920.0991707702301" Width="164.127899594293" Height="28.198341540460206" ZOrder="32768" FontWeight="Bold" FontSize="12" Valign="Middle" Color="14961e" />
    <Xref Database="WikiPathways" ID="WP769" />
  </DataNode>
  <DataNode TextLabel="PLC-γ1" GraphId="b9354" Type="Protein">
    <Graphics CenterX="2017.6879432624169" CenterY="721.9716312056738" Width="60.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P19174" />
  </DataNode>
  <DataNode TextLabel="VAV1" GraphId="bad38" Type="Protein">
    <Graphics CenterX="1266.6277971128868" CenterY="691.8710128807775" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P15498" />
  </DataNode>
  <DataNode TextLabel="SHP-1" GraphId="bd3ee" Type="Protein" GroupRef="b2f4f">
    <Graphics CenterX="1404.274789805416" CenterY="521.2622439094416" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P29350" />
  </DataNode>
  <DataNode TextLabel="SHP-2" GraphId="bd926" Type="Protein" GroupRef="b2f4f">
    <Comment></Comment>
    <Graphics CenterX="1404.369165969831" CenterY="548.5611508563272" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P17706" />
  </DataNode>
  <DataNode TextLabel="PKC" GraphId="be0c0" Type="Protein" GroupRef="ae110">
    <Graphics CenterX="2211.3546099290816" CenterY="791.304964539006" Width="60.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q04759" />
  </DataNode>
  <DataNode TextLabel="CD34(+)" GraphId="be186">
    <Comment>CD133-positive hematopoietic stem cell is a hematopoietic stem cell that is CD34-positive, CD90-positive, and CD133-positive.</Comment>
    <Comment>Cell type ontology: CL:0001024</Comment>
    <Graphics CenterX="167.30418976101055" CenterY="90.33577686393716" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="" ID="" />
  </DataNode>
  <DataNode TextLabel="VEGFA-VEGFR2 Pathway" GraphId="be22f" Type="Pathway">
    <Comment>This pathway is critical for EVT function and spiral artery remodeling, and its disruption is linked to pregnancy complications such as preeclampsia and recurrent pregnancy loss</Comment>
    <BiopaxRef>bb4</BiopaxRef>
    <Graphics CenterX="1821.3333333333337" CenterY="1179.2216312056726" Width="220.0" Height="39.16666666666621" ZOrder="32768" FontWeight="Bold" FontSize="12" Valign="Middle" Color="14961e" />
    <Xref Database="WikiPathways" ID="WP3888" />
  </DataNode>
  <DataNode TextLabel="VAV1" GraphId="c3095" Type="Protein">
    <Graphics CenterX="1266.6277971128868" CenterY="610.2240201882453" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P15498" />
  </DataNode>
  <DataNode TextLabel="NF-kb" GraphId="c4fb3" Type="Pathway">
    <Graphics CenterX="2241.6879432624078" CenterY="1069.6382978723427" Width="90.0" Height="25.0" ZOrder="32768" FontWeight="Bold" FontSize="12" Valign="Middle" Color="14961e" />
    <Xref Database="WikiPathways" ID="WP4562" />
  </DataNode>
  <DataNode TextLabel="SLP-76" GraphId="cb07e" Type="Protein">
    <Graphics CenterX="1550.354609929079" CenterY="614.6382978723398" Width="60.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q13094" />
  </DataNode>
  <DataNode TextLabel="TNF-α" GraphId="d2c9b" Type="Protein" GroupRef="e4b79">
    <Comment>Via its action on endometrial stromal cells, TNF-α can also indirectly promote trophoblast invasion by creating a supportive inflammatory environment</Comment>
    <Comment>Elevated TNF-α impairs trophoblast migration and invasion</Comment>
    <Comment>This duality highlights the importance of tightly regulated TNF-α signaling for successful implantation and placental development</Comment>
    <BiopaxRef>fc6</BiopaxRef>
    <BiopaxRef>de8</BiopaxRef>
    <Graphics CenterX="2043.021276595747" CenterY="1199.6382978723377" Width="60.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P01375" />
  </DataNode>
  <DataNode TextLabel="PI3K-Akt Pathway" GraphId="d54ed" Type="Pathway">
    <Graphics CenterX="1688.8284090557133" CenterY="922.2904084982472" Width="120.0" Height="25.0" ZOrder="32768" FontWeight="Bold" FontSize="12" Valign="Middle" Color="14961e" />
    <Xref Database="WikiPathways" ID="WP4172" />
  </DataNode>
  <DataNode TextLabel="KIR2DL1" GraphId="d5ba0" Type="Protein">
    <Comment>
Cytoplasmic tail contains ITIM motif</Comment>
    <Graphics CenterX="1397.0043690057412" CenterY="391.27656675898874" Width="113.76222596964281" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P43626" />
  </DataNode>
  <DataNode TextLabel="ELF3" GraphId="d8449" Type="Protein">
    <Comment>Expression: Differentially expressed
Measurement: RNA-seq
Role: Transcription factor that may regulate HLA-C
Source: GSE241792 (ELF3/NLRP7 KO vs WT)</Comment>
    <Graphics CenterX="1538.3333333333355" CenterY="48.000000000000085" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q5SR36" />
  </DataNode>
  <DataNode TextLabel="EVT cell" GraphId="dd156">
    <Comment>Extravillous trophoblast. A trophoblast cell that is not part of a placental villous. Extravillous trophoblasts (EVTs), a specialized subset of trophoblast cells, play crucial roles in establishing and sustaining pregnancy.</Comment>
    <Comment>Cell type ontology: CL:0008036</Comment>
    <Graphics CenterX="1258.177304964539" CenterY="56.985815602836375" Width="88.9787234042542" Height="22.028368794326852" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="" ID="" />
  </DataNode>
  <DataNode TextLabel="FYN" GraphId="e0dd7" Type="Protein">
    <Graphics CenterX="1610.6326303075355" CenterY="464.0283997646229" Width="60.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P06241" />
  </DataNode>
  <DataNode TextLabel="LAT" GraphId="e219d" Type="Protein">
    <Graphics CenterX="1818.3546099290786" CenterY="574.3049645390029" Width="60.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="O43561" />
  </DataNode>
  <DataNode TextLabel="RAC1" GraphId="e3ead" Type="Protein">
    <Graphics CenterX="1888.7483723958335" CenterY="800.2547602191023" Width="60.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P63000" />
  </DataNode>
  <DataNode TextLabel="dNK cell" GraphId="e6f9c">
    <Comment>Decidual natural killer cell. A natural killer cell subset that is found in the decidual of the uterus CD56brightCD16- phenotype. This cell type represents the most abundant immune cell type in the decidual during the first trimester of pregnancy.</Comment>
    <Comment>Cell type ontology: CL:0002343</Comment>
    <Graphics CenterX="2204.187943262412" CenterY="505.7216312056746" Width="138.33333333333212" Height="35.1666666666651" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="" ID="" />
  </DataNode>
  <DataNode TextLabel="PBNK cell" GraphId="e7430">
    <Comment>Peripheral blood natural killer cell. A lymphocyte that can spontaneously kill a variety of target cells without prior antigenic activation via germline encoded activation receptors and also regulate immune responses via cytokine release and direct contact with other cells.</Comment>
    <Comment>Cell type ontology: CL:0000623</Comment>
    <Graphics CenterX="457.49466595148556" CenterY="96.64950235413363" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="" ID="" />
  </DataNode>
  <DataNode TextLabel="NLRP7" GraphId="e8ee1" Type="Protein">
    <Comment>Expression: Differentially expressed (significant)
Measurement: RNA-seq
Role: upstream regulator of HLA-C
Source: GSE241792 (ELF3/NLRP7 KO vs WT)</Comment>
    <Graphics CenterX="1466.3333333333326" CenterY="124.66666666666637" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q8WX94" />
  </DataNode>
  <DataNode TextLabel="IP3" GraphId="ed936" Type="Protein">
    <Graphics CenterX="2017.6879432624169" CenterY="802.638297872338" Width="60.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q14643" />
  </DataNode>
  <DataNode TextLabel="DAP12" GraphId="f23be" Type="Protein" GroupRef="bcb50">
    <Comment>Contains immunoreceptor tyrosine-based activation motif (ITAM)</Comment>
    <BiopaxRef>fc2</BiopaxRef>
    <Graphics CenterX="1889.2468952274805" CenterY="413.9759980179013" Width="60.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="O43914" />
  </DataNode>
  <DataNode TextLabel="KIR2DL2 " GraphId="f764e" Type="Protein">
    <Graphics CenterX="1268.0212765957447" CenterY="391.8882978723407" Width="100.0" Height="28.5" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P43627" />
  </DataNode>
  <DataNode TextLabel="TNF-alpha signaling" GraphId="f80e4" Type="Pathway">
    <Comment>This pathway details the signaling events initiated by TNF-α, including activation of NF-κB, apoptosis, and inflammatory gene expression. While it is not trophoblast-specific, the pathway covers the core mechanisms by which TNF-α regulates immune responses and cell behavior, which are directly relevant to its roles in immune regulation and inhibition of trophoblast invasion.</Comment>
    <Graphics CenterX="2225.18794326241" CenterY="1201.7216312056696" Width="167.66666666666606" Height="47.166666666666075" ZOrder="32768" FontWeight="Bold" FontSize="12" Valign="Middle" Color="14961e" />
    <Xref Database="WikiPathways" ID="WP231" />
  </DataNode>
  <DataNode TextLabel="NK-precursor cell" GraphId="f8889">
    <Comment>CD34 (-)CD117(+)CD94(-) NK precursor cells in the peripheral blood</Comment>
    <Comment> Cell type ontology CL:0000823</Comment>
    <Graphics CenterX="789.9624530663344" CenterY="93.0332558555354" Width="174.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="" ID="" />
  </DataNode>
  <DataNode TextLabel="KIR2DS1" GraphId="fb5e1" Type="Protein" GroupRef="bcb50">
    <Graphics CenterX="1889.2468952274805" CenterY="393.9759980179013" Width="60.0" Height="20.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q14954" />
  </DataNode>
  <DataNode TextLabel="Type II interferon signaling" GraphId="fbf87" Type="Pathway">
    <Comment>The canonical IFN-γ signaling pathway, including JAK/STAT activation and downstream gene regulation. While it does not specifically mention trophoblasts, it shows how IFN-γ can induce gene expression changes leading to apoptosis and immune modulation.</Comment>
    <Graphics CenterX="1820.6666666666672" CenterY="1218.735815602835" Width="220.0" Height="39.16666666666621" ZOrder="32768" FontWeight="Bold" FontSize="12" Valign="Middle" Color="14961e" />
    <Xref Database="WikiPathways" ID="WP619" />
  </DataNode>
  <DataNode TextLabel="KIR2DL3" GraphId="ff8bb" Type="Protein">
    <Graphics CenterX="1143.0212765957447" CenterY="391.8882978723407" Width="104.0" Height="28.5" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P43628" />
  </DataNode>
  <DataNode TextLabel="HLA-C" GraphId="a7585" Type="Protein">
    <Graphics CenterX="1246.6246244851159" CenterY="262.93269379665054" Width="93.03493449781669" Height="27.056040756914175" ZOrder="32770" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P10321" />
  </DataNode>
  <DataNode TextLabel="HLA-C" GraphId="f409b" Type="Protein">
    <Graphics CenterX="1832.5880662400905" CenterY="264.89689219572944" Width="90.0" Height="25.0" ZOrder="32772" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P10321" />
  </DataNode>
  <DataNode TextLabel="VAV1" GraphId="fd79d" Type="Protein">
    <Graphics CenterX="1888.7483723958335" CenterY="724.535519460444" Width="60.0" Height="20.0" ZOrder="32774" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P15498" />
  </DataNode>
  <DataNode TextLabel="SLP-76" GraphId="c4ee3" Type="Protein">
    <Graphics CenterX="1943.4138233137578" CenterY="574.3049645390029" Width="60.0" Height="20.0" ZOrder="32775" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q13094" />
  </DataNode>
  <DataNode TextLabel="FYN" GraphId="ae538" Type="Protein">
    <Graphics CenterX="1044.6326303075355" CenterY="469.02839976462315" Width="90.0" Height="25.0" ZOrder="32777" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P06241" />
  </DataNode>
  <DataNode TextLabel="HLA-C" GraphId="b55de" Type="Protein">
    <Graphics CenterX="1538.819675431258" CenterY="198.57752640218024" Width="93.03493449781669" Height="27.056040756914175" ZOrder="32782" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P10321" />
  </DataNode>
  <State GraphRef="f764e" TextLabel="P" GraphId="affea">
    <Comment>Phosphorylated state</Comment>
    <BiopaxRef>f4e</BiopaxRef>
    <Graphics RelX="1.0" RelY="1.0" Width="15.0" Height="15.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="c3095" TextLabel="P" GraphId="b1f1e">
    <Graphics RelX="1.0" RelY="1.0" Width="15.0" Height="15.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="bd3ee" TextLabel="" GraphId="b61ca">
    <Attribute Key="org.pathvisio.core.StateRotation" Value="4.71238898038469" />
    <Graphics RelX="-1.0" RelY="-1.0" Width="15.0" Height="15.0" FillColor="ff6600" Color="ff6600" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="e8ee1" TextLabel="" GraphId="c2639">
    <Comment></Comment>
    <BiopaxRef>ea7</BiopaxRef>
    <Graphics RelX="-1.0" RelY="-1.0" Width="15.0" Height="15.0" FillColor="0000ff" ShapeType="Oval" Color="0000ff" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="b3802" TextLabel="C2" GraphId="c32a6">
    <Comment>Lysine at position 80; KIR2DL1/KIR2DS1 ligand; HLA-C2 group.</Comment>
    <Graphics RelX="1.0" RelY="1.0" Width="40.0" Height="30.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="cb07e" TextLabel="P" GraphId="ccb7a">
    <Graphics RelX="1.0" RelY="1.0" Width="15.0" Height="15.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="d5ba0" TextLabel="" GraphId="d86e6">
    <Comment>Maternal KIR Genotype: Women with the KIR AA genotype, which lacks activating KIR genes, were found to have an increased risk of pregnancy complications.</Comment>
    <Comment>Interaction Outcome: The combination of maternal centromeric KIR AA genotype and fetal HLA-C2 allele led to over-inhibition of dNK cells, impairing trophoblast invasion and spiral artery remodeling, processes essential for successful placentation.</Comment>
    <Comment>Pregnancy Complications: This over-inhibition was associated with increased risks of recurrent pregnancy loss (RPL)</Comment>
    <BiopaxRef>d24</BiopaxRef>
    <Attribute Key="org.pathvisio.core.StateRotation" Value="4.71238898038469" />
    <Graphics RelX="-1.0" RelY="-1.0" Width="15.0" Height="15.0" FillColor="ff6600" Color="ff6600" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="ff8bb" TextLabel="P" GraphId="d9439">
    <Comment>Phosphorylated state</Comment>
    <BiopaxRef>f4e</BiopaxRef>
    <Graphics RelX="1.0" RelY="1.0" Width="15.0" Height="15.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="b4c30" TextLabel="" GraphId="de69f">
    <BiopaxRef>ea7</BiopaxRef>
    <Graphics RelX="-1.0" RelY="-1.0" Width="15.0" Height="15.0" FillColor="0000ff" ShapeType="Oval" Color="0000ff" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="b3802" TextLabel="" GraphId="e41ed">
    <Comment>Fetal HLA-C2 Allele: When the fetus inherited the HLA-C2 allele (which encodes lysine at position 80), there was a stronger inhibitory interaction with maternal KIR2DL1 receptors.</Comment>
    <Comment>The combination of maternal centromeric KIR AA genotype and fetal HLA-C2 allele led to over-inhibition of dNK cells, impairing trophoblast invasion and spiral artery remodeling, processes essential for successful placentation.</Comment>
    <Comment>This over-inhibition was associated with increased risks of recurrent pregnancy loss (RPL).</Comment>
    <BiopaxRef>d24</BiopaxRef>
    <Attribute Key="org.pathvisio.core.StateRotation" Value="4.71238898038469" />
    <Graphics RelX="-1.0" RelY="-1.0" Width="15.0" Height="15.0" FillColor="ff6600" Color="ff6600" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="bd926" TextLabel="" GraphId="e61cb">
    <Attribute Key="org.pathvisio.core.StateRotation" Value="4.71238898038469" />
    <Graphics RelX="-1.0" RelY="-1.0" Width="15.0" Height="15.0" FillColor="ff6600" Color="ff6600" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="f23be" TextLabel="P" GraphId="e75c2">
    <Comment>Phosphorylation state</Comment>
    <Graphics RelX="1.0" RelY="1.0" Width="15.0" Height="20.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="d5ba0" TextLabel="P" GraphId="eb6be">
    <Comment>Phosphorylation state</Comment>
    <BiopaxRef>f4e</BiopaxRef>
    <Graphics RelX="1.0" RelY="1.0" Width="15.0" Height="15.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="d8449" TextLabel="" GraphId="f1f37">
    <BiopaxRef>ea7</BiopaxRef>
    <Graphics RelX="-1.0" RelY="-1.0" Width="15.0" Height="15.0" FillColor="0000ff" ShapeType="Oval" Color="0000ff" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="a47bc" TextLabel="C1" GraphId="f9942">
    <Comment>Asparagine at position 80; KIR2DL1/KIR2DS1 ligand; HLA-C1 group.</Comment>
    <Graphics RelX="1.0" RelY="1.0" Width="40.0" Height="30.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="e219d" TextLabel="P" GraphId="ff62f">
    <Graphics RelX="1.0" RelY="1.0" Width="15.0" Height="20.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="a7585" TextLabel="C1" GraphId="aa100">
    <Comment>Asparagine at position 80; KIR2DL1/KIR2DS1 ligand; HLA-C1 group.</Comment>
    <Graphics RelX="1.0" RelY="1.0" Width="40.0" Height="30.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="f409b" TextLabel="C2" GraphId="ec253">
    <Comment>Lysine at position 80; KIR2DL1/KIR2DS1 ligand; HLA-C2 group.</Comment>
    <Graphics RelX="1.0" RelY="1.0" Width="40.0" Height="30.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="fd79d" TextLabel="P" GraphId="afb8f">
    <Graphics RelX="1.0" RelY="1.0" Width="15.0" Height="20.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="c4ee3" TextLabel="P" GraphId="afadb">
    <Graphics RelX="1.0" RelY="1.0" Width="15.0" Height="20.0" ShapeType="Oval" />
    <Xref Database="" ID="" />
  </State>
  <State GraphRef="b55de" TextLabel="" GraphId="a9817">
    <BiopaxRef>ea7</BiopaxRef>
    <Graphics RelX="-1.0" RelY="-0.9223522630302958" Width="15.0" Height="15.0" FillColor="0000ff" ShapeType="Oval" Color="0000ff" />
    <Xref Database="" ID="" />
  </State>
  <Interaction GraphId="id14520dbf">
    <Comment>Phosphorylated ITIM recruits SHP-1 via their SH2 domains, initiating inhibitory signaling</Comment>
    <Comment>Flow cytometry evidence and biological system reconstruction evidence based on inference from background 
</Comment>
    <Comment>Inferred from human pbNK cells</Comment>
    <Comment>ECO:0000268, ECO:0005547</Comment>
    <BiopaxRef>d27</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1268.0212765957447" Y="406.1382978723407" GraphRef="f764e" RelX="0.0" RelY="1.0" />
      <Point X="1377.79838384652" Y="500.7622439094416" GraphRef="add72" RelX="-0.5" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id1fa7de01">
    <Comment>Phosphorylation of ITAM recruites and activates Syk</Comment>
    <Comment>flow cytometry evidence</Comment>
    <Comment>ECO:0000268</Comment>
    <BiopaxRef>e33</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1889.2468952274805" Y="431.9759980179013" GraphRef="f8626" RelX="0.0" RelY="1.0" />
      <Point X="1890.419474807723" Y="488.55029628162794" GraphRef="b46a5" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id201a7765">
    <Comment>ITIM phosphorylation</Comment>
    <Comment>Mass spectometry evidence</Comment>
    <Comment>Inferred from human pbNK cells</Comment>
    <Comment>ECO:0001096</Comment>
    <BiopaxRef>cac</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1067.1326303075355" Y="456.52839976462315" GraphRef="ae538" RelX="0.5" RelY="-1.0" />
      <Point X="1117.0212765957447" Y="406.1382978723407" GraphRef="ff8bb" RelX="-0.5" RelY="1.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id24a19f3d">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="1538.3333333333355" Y="60.500000000000085" GraphRef="d8449" RelX="0.0" RelY="1.0" />
      <Point X="1596.9999999999984" Y="117.16666666666637" GraphRef="b4c30" RelX="0.0" RelY="-1.0" ArrowHead="mim-inhibition" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id26ffd46c">
    <BiopaxRef>bb6</BiopaxRef>
    <BiopaxRef>d41</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="458.76553736919084" Y="148.78386166278386" GraphRef="b1078" RelX="0.0" RelY="1.0" />
      <Point X="454.1579256904557" Y="335.43723363551385" GraphRef="a81fa" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id2a40a981">
    <Comment>Trancriptomic data does not diffirentiate between HLA-C1 and C2 allotypes.</Comment>
    <Graphics ZOrder="12288" LineStyle="Broken" LineThickness="1.0">
      <Point X="1538.819675431258" Y="212.10554678063733" GraphRef="b55de" RelX="0.0" RelY="1.0" />
      <Point X="1666.819675431258" Y="247.04950602372315" GraphRef="a47bc" RelX="0.0" RelY="-1.0" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id2b1265ec">
    <Comment>Functional readout</Comment>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1172.0639497971465" Y="934.1983415404602" GraphRef="b6ee0" RelX="0.0" RelY="1.0" />
      <Point X="1332.3439716312066" Y="984.8333333333346" GraphRef="b1d91" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
      <Anchor Position="0.5128760293857632" Shape="None" GraphId="f1455" />
      <Anchor Position="0.3139941074576366" Shape="None" GraphId="ec272" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id38026a2f">
    <Comment>combinatorial experimental and author inference evidence</Comment>
    <Comment>ECO:0007011</Comment>
    <BiopaxRef>cf9</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="2241.6879432624078" Y="1082.1382978723427" GraphRef="c4fb3" RelX="0.0" RelY="1.0" />
      <Point X="2043.0212765957467" Y="1161.6382978723377" GraphRef="b2f2c" RelX="0.0" RelY="-1.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id412c3a70">
    <Comment>SHP-1/2 dephosphorylate Vav1 blocking activation signals</Comment>
    <Comment>immunofluorescence evidence</Comment>
    <Comment>Inferred from human NK cells</Comment>
    <Comment>ECO:0000007</Comment>
    <BiopaxRef>e25</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1377.79838384652" Y="569.0611508563272" GraphRef="add72" RelX="-0.5" RelY="1.0" />
      <Point X="1266.6277971128868" Y="597.7240201882453" GraphRef="c3095" RelX="0.0" RelY="-1.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id447bfd0d">
    <Comment>Rac1 activation is required for the granule dynamics underlying NK cell degranulation</Comment>
    <Comment>Flow cytometry, enzyme assays</Comment>
    <BiopaxRef>c43</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1888.7483723958335" Y="810.2547602191023" GraphRef="e3ead" RelX="0.0" RelY="1.0" />
      <Point X="1891.521276595745" Y="930.9716312056728" GraphRef="d49e4" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id47d3e6e2" GroupRef="e21e5">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="2159.232492997201" Y="325.48964539429056" />
      <Point X="2205.8991596638652" Y="325.21008403361316" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id4e73cf05">
    <Comment>Binding HLA-C1 to KIR2DL3 </Comment>
    <Comment>functional complementation evidence</Comment>
    <Comment>ECO:0000012</Comment>
    <BiopaxRef>c23</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1246.6246244851159" Y="276.4607141751076" GraphRef="a7585" RelX="0.0" RelY="1.0" />
      <Point X="1143.0212765957447" Y="377.6382978723407" GraphRef="ff8bb" RelX="0.0" RelY="-1.0" ArrowHead="mim-binding" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id51729190">
    <Comment>Reduced degranulation</Comment>
    <Comment>combinatorial experimental and author inference evidence</Comment>
    <Comment>ECO:0007011</Comment>
    <BiopaxRef>e33</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1266.6277971128868" Y="622.7240201882453" GraphRef="c3095" RelX="0.0" RelY="1.0" />
      <Point X="1266.6277971128868" Y="679.3710128807775" GraphRef="bad38" RelX="0.0" RelY="-1.0" ArrowHead="mim-modification" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id519c0edc">
    <Comment>None/ very low affinity binding of KIR2DL1 to HLA-C1</Comment>
    <BiopaxRef>c1e</BiopaxRef>
    <Graphics ZOrder="12288" LineStyle="Broken" LineThickness="1.0">
      <Point X="1269.88335810957" Y="276.4607141751076" GraphRef="a7585" RelX="0.5" RelY="1.0" />
      <Point X="1368.5638125133305" Y="378.77656675898874" GraphRef="d5ba0" RelX="-0.5" RelY="-1.0" ArrowHead="mim-binding" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id5250ae5e" GroupRef="e21e5">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="2160.747873856574" Y="267.8767507002799" />
      <Point X="2207.414540523241" Y="267.8767507002799" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id591de173">
    <Comment>Phosphorylated ITIM recruits SHP via their SH2 domains, initiating inhibitory signaling</Comment>
    <Comment>fluorescence resonance energy transfer evidence</Comment>
    <Comment>Inferred from pbNK cells</Comment>
    <Comment>ECO:0001048</Comment>
    <BiopaxRef>f58</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1368.5638125133305" Y="403.77656675898874" GraphRef="d5ba0" RelX="-0.5" RelY="1.0" />
      <Point X="1404.369165969831" Y="536.0611508563272" GraphRef="bd926" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id5c6fc4fd">
    <Comment>Phosphorylate tyrosine residues in ITAM
</Comment>
    <Comment>mass spectrometry evidence</Comment>
    <Comment>Inferred from human pbNK cells</Comment>
    <Comment>ECO:0001096</Comment>
    <BiopaxRef>c8a</BiopaxRef>
    <BiopaxRef>cac</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1640.6326303075355" Y="459.0283997646229" GraphRef="e0dd7" RelX="1.0" RelY="-0.5" />
      <Point X="1859.2468952274805" Y="413.9759980179013" GraphRef="f23be" RelX="-1.0" RelY="0.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id5e36b367">
    <Comment>ECO:0007011</Comment>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="2073.0212765957467" Y="1199.6382978723377" GraphRef="d2c9b" RelX="1.0" RelY="0.0" />
      <Point X="2141.354609929077" Y="1201.7216312056696" GraphRef="f80e4" RelX="-1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id670852a0">
    <BiopaxRef>f10</BiopaxRef>
    <BiopaxRef>a00</BiopaxRef>
    <BiopaxRef>a29</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="181.25056460099668" Y="285.5629297824405" GraphRef="fb9fd" RelX="0.0" RelY="-1.0" />
      <Point X="323.56244641126375" Y="221.69357920514676" GraphRef="a225c" RelX="0.0" RelY="0.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id6c0cd2be">
    <Comment>LAT activation leads to MAPK pathway activation</Comment>
    <Comment>Inferred from human NK cells</Comment>
    <Comment>combinatorial experimental and author inference evidence</Comment>
    <Comment>ECO:0007011</Comment>
    <BiopaxRef>c58</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1803.3546099290786" Y="584.3049645390029" GraphRef="e219d" RelX="-0.5" RelY="1.0" />
      <Point X="1254.2677309852627" Y="960.1678150791704" GraphRef="f1455" RelX="0.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id6d77343c">
    <Comment>Suppressed proliferation</Comment>
    <Comment>combinatorial experimental and author inference evidence</Comment>
    <Comment>ECO:0007011</Comment>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1404.3219778876237" Y="569.0611508563272" GraphRef="add72" RelX="0.0" RelY="1.0" />
      <Point X="1222.3909321962228" Y="950.0974305945886" GraphRef="ec272" RelX="0.0" RelY="0.0" ArrowHead="mim-inhibition" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id70ac67a8">
    <Comment>Phosphorylated ITIM recruits SHP-1 via their SH2 domains, initiating inhibitory signaling</Comment>
    <Comment>Flow cytometry evidence and biological system reconstruction evidence based on inference from background </Comment>
    <Comment>inferred from human pbNK cells</Comment>
    <Comment>ECO:0000268, ECO:0005547</Comment>
    <BiopaxRef>d27</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1169.0212765957447" Y="406.1382978723407" GraphRef="ff8bb" RelX="0.5" RelY="1.0" />
      <Point X="1351.2747898054163" Y="517.8369706461631" GraphRef="add72" RelX="-1.0" RelY="-0.5" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id714c9329">
    <Comment>Phosphorylated ITIM recruits SHP-1 via their SH2 domains, initiating inhibitory signaling</Comment>
    <Comment>fluorescence resonance energy transfer evidence</Comment>
    <Comment>Inferred from Human NK cell line (YTS) expressing KIR2DL1</Comment>
    <Comment>ECO:0001048</Comment>
    <BiopaxRef>e25</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1425.4449254981519" Y="403.77656675898874" GraphRef="d5ba0" RelX="0.5" RelY="1.0" />
      <Point X="1404.274789805416" Y="508.7622439094416" GraphRef="bd3ee" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id71662cba">
    <Comment>Inferred from pbNK cells</Comment>
    <Comment>combinatorial experimental and author inference evidence</Comment>
    <Comment>ECO:0007011</Comment>
    <BiopaxRef>cf9</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="2158.687943262415" Y="731.9716312056738" GraphRef="a7d6d" RelX="0.0" RelY="1.0" />
      <Point X="2210.687943262418" Y="773.304964539006" GraphRef="de96c" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id7558f2d1">
    <Comment>CD56brightCD16- phenotype (dNK cell)</Comment>
    <BiopaxRef>fca</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="602.8059020816868" Y="403.14085926789164" GraphRef="a81fa" RelX="1.0" RelY="0.0" />
      <Point X="914.687943262416" Y="571.2287234042556" GraphRef="b1ea3" RelX="-1.0" RelY="-0.5" ArrowHead="mim-conversion" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id7887850f">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1605.354609929082" Y="1070.1666666666647" GraphRef="bf587" RelX="0.0" RelY="1.0" />
      <Point X="1605.3546099290822" Y="1163.9716312056696" GraphRef="aad35" RelX="0.0" RelY="-1.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id796bc9fb">
    <Comment>combinatorial experimental and author inference evidence</Comment>
    <Comment>ECO:0007011</Comment>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1404.3219778876237" Y="569.0611508563272" GraphRef="add72" RelX="0.0" RelY="1.0" />
      <Point X="1662.1179246926283" Y="951.123452638067" GraphRef="abed1" RelX="0.0" RelY="0.0" ArrowHead="mim-inhibition" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id8308023b">
    <Comment>ECO:0007011</Comment>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="2013.0212765957467" Y="1219.6382978723377" GraphRef="a97ea" RelX="-1.0" RelY="0.0" />
      <Point X="1930.6666666666672" Y="1218.735815602835" GraphRef="fbf87" RelX="1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id83ad5924" GroupRef="e21e5">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="2157.916290197718" Y="178.54341736694693" />
      <Point X="2209.916290197718" Y="178.54341736694693" ArrowHead="mim-binding" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id8b59bcfa">
    <Comment>NF-kB pathway activation</Comment>
    <Comment>combinatorial experimental and author inference evidence</Comment>
    <Comment>ECO:0007011</Comment>
    <BiopaxRef>cf9</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="2237.187943262418" Y="839.1382978723373" GraphRef="de96c" RelX="0.5" RelY="1.0" />
      <Point X="2241.6879432624078" Y="1057.1382978723427" GraphRef="c4fb3" RelX="0.0" RelY="-1.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id8f5d8ae1">
    <BiopaxRef>fb5</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="602.8059020816868" Y="403.14085926789164" GraphRef="a81fa" RelX="1.0" RelY="0.0" />
      <Point X="746.035548493374" Y="703.52905417486" GraphRef="a2eae" RelX="0.5" RelY="-1.0" ArrowHead="mim-conversion" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id958c9d45">
    <Comment>LAT activation leads to activation of PI3K-Akt pathway</Comment>
    <Comment>Inferred from human NK cells</Comment>
    <BiopaxRef>cf9</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1833.3546099290786" Y="584.3049645390029" GraphRef="e219d" RelX="0.5" RelY="1.0" />
      <Point X="1688.8284090557133" Y="909.7904084982472" GraphRef="d54ed" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id9c349059">
    <Comment>combinatorial experimental and author inference evidence</Comment>
    <Comment>ECO:0007011</Comment>
    <BiopaxRef>fb1</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1550.354609929079" Y="624.6382978723398" GraphRef="cb07e" RelX="0.0" RelY="1.0" />
      <Point X="1550.354609929079" Y="673.9716312056739" GraphRef="a8080" RelX="0.0" RelY="-1.0" ArrowHead="mim-modification" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id9da0dad6">
    <Comment>High-affinity interaction between HLA-C2 and KIR2DL1</Comment>
    <Comment> CD107a degranulation assay,  Flow cytometry evidence</Comment>
    <Comment>ECO:0000268</Comment>
    <BiopaxRef>c23</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1395.671035672408" Y="274.6749125741872" GraphRef="b3802" RelX="0.0" RelY="1.0" />
      <Point X="1397.0043690057412" Y="378.77656675898874" GraphRef="d5ba0" RelX="0.0" RelY="-1.0" ArrowHead="mim-binding" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id9f44df4">
    <Comment>No affinity binding of HLA-C1 to KIR2DS1</Comment>
    <BiopaxRef>a90</BiopaxRef>
    <Graphics ZOrder="12288" LineStyle="Broken" LineThickness="1.0">
      <Point X="1643.5609418068038" Y="274.1055467806373" GraphRef="a47bc" RelX="-0.5" RelY="1.0" />
      <Point X="1889.2468952274805" Y="383.9759980179013" GraphRef="fb5e1" RelX="0.0" RelY="-1.0" ArrowHead="mim-binding" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="ida57f15f9">
    <Comment> Affinity binding of HLA-C2 to KIR2DS1</Comment>
    <Comment>flow cytometry evidence</Comment>
    <Comment>ECO:0000268</Comment>
    <BiopaxRef>a90</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1832.5880662400905" Y="277.39689219572944" GraphRef="f409b" RelX="0.0" RelY="1.0" />
      <Point X="1904.2468952274805" Y="383.9759980179013" GraphRef="fb5e1" RelX="0.5" RelY="-1.0" ArrowHead="mim-binding" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="ida5c94156">
    <Comment>qualitative western immunoblotting evidence</Comment>
    <Comment>ECO:0000112</Comment>
    <BiopaxRef>c8a</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="2047.6879432624169" Y="721.9716312056738" GraphRef="b9354" RelX="1.0" RelY="0.0" />
      <Point X="2128.687943262415" Y="721.9716312056738" GraphRef="a7d6d" RelX="-1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="ida6294477">
    <Comment>SHP-1/2 dephosphorylate SLP-76, blocking activation signals</Comment>
    <Comment>co-immunoprecipitation evidence </Comment>
    <Comment>Inferred from human NK cells</Comment>
    <Comment>ECO:0000070</Comment>
    <BiopaxRef>fb1</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1430.8455719287274" Y="569.0611508563272" GraphRef="add72" RelX="0.5" RelY="1.0" />
      <Point X="1550.354609929079" Y="604.6382978723398" GraphRef="cb07e" RelX="0.0" RelY="-1.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idac89866f" GroupRef="e21e5">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="2158.613445378151" Y="207.98319327731105" />
      <Point X="2208.5879210570934" Y="208.2057607100457" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idad003040">
    <Comment>small interfering RNA knockdown evidence</Comment>
    <Comment>ECO:0001583</Comment>
    <Comment>Inferred from human NK cells</Comment>
    <BiopaxRef>bf3</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1958.4138233137578" Y="584.3049645390029" GraphRef="c4ee3" RelX="0.5" RelY="1.0" />
      <Point X="2017.6879432624169" Y="711.9716312056738" GraphRef="b9354" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idbb259781">
    <Comment>Binding KIR2DL2 to HLA-C1</Comment>
    <Comment>functional complementation evidence</Comment>
    <Comment>ECO:0000012</Comment>
    <BiopaxRef>c23</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1246.6246244851159" Y="276.4607141751076" GraphRef="a7585" RelX="0.0" RelY="1.0" />
      <Point X="1268.0212765957447" Y="377.6382978723407" GraphRef="f764e" RelX="0.0" RelY="-1.0" ArrowHead="mim-binding" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idbc16df37" GroupRef="e21e5">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="2160.5869851846983" Y="241.2100840336135" />
      <Point X="2207.2457579711563" Y="241.2100840336135" ArrowHead="mim-modification" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idbe42dc32">
    <Comment>ITIM phosphorylation</Comment>
    <Comment>mass spectrometry evidence</Comment>
    <Comment>Inferred from human pbNK cells</Comment>
    <Comment>ECO:0001096</Comment>
    <BiopaxRef>cac</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1580.6326303075355" Y="459.0283997646229" GraphRef="e0dd7" RelX="-1.0" RelY="-0.5" />
      <Point X="1425.4449254981519" Y="403.77656675898874" GraphRef="d5ba0" RelX="0.5" RelY="1.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idbfb960a4">
    <Comment>small interfering RNA knockdown evidence and knockout phenotypic evidence</Comment>
    <Comment>ECO:0001583 ,ECO:0001091</Comment>
    <BiopaxRef>c43</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1888.7483723958335" Y="734.535519460444" GraphRef="fd79d" RelX="0.0" RelY="1.0" />
      <Point X="1888.7483723958335" Y="790.2547602191023" GraphRef="e3ead" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idc2d0270">
    <Comment>combinatorial experimental and author inference evidence</Comment>
    <Comment>ECO:0007011</Comment>
    <BiopaxRef>cf9</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="2017.6879432624169" Y="731.9716312056738" GraphRef="b9354" RelX="0.0" RelY="1.0" />
      <Point X="2017.6879432624169" Y="792.638297872338" GraphRef="ed936" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idc5968221">
    <Comment>combinatorial experimental and author inference evidence</Comment>
    <Comment>ECO:0007011</Comment>
    <BiopaxRef>cf9</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="2017.6879432624169" Y="812.638297872338" GraphRef="ed936" RelX="0.0" RelY="1.0" />
      <Point X="2124.521276595744" Y="907.3049645389979" GraphRef="f2e67" RelX="-0.5" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idc6d1874d">
    <Comment>co-immunoprecipitation evidence</Comment>
    <Comment>ECO:0000070</Comment>
    <BiopaxRef>e33</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1890.419474807723" Y="508.55029628162794" GraphRef="b46a5" RelX="0.0" RelY="1.0" />
      <Point X="1943.4138233137578" Y="564.3049645390029" GraphRef="c4ee3" RelX="0.0" RelY="-1.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idc9eb38d5">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="1493.3333333333355" Y="48.000000000000085" GraphRef="d8449" RelX="-1.0" RelY="0.0" />
      <Point X="1341.0" Y="123.28876320109016" />
      <Point X="1492.3022081823497" Y="198.57752640218024" GraphRef="b55de" RelX="-1.0" RelY="0.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idca148a64">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="1596.9999999999984" Y="142.16666666666637" GraphRef="b4c30" RelX="0.0" RelY="1.0" />
      <Point X="1562.0784090557122" Y="185.04950602372315" GraphRef="b55de" RelX="0.5" RelY="-1.0" ArrowHead="mim-inhibition" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idceb4ec7a">
    <Comment>Inferred from human pbNK cell </Comment>
    <Comment>flow cytometry evidence</Comment>
    <Comment>ECO:0000268</Comment>
    <BiopaxRef>cf9</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="2157.0212765957435" Y="907.3049645389979" GraphRef="f2e67" RelX="0.0" RelY="-1.0" />
      <Point X="2210.687943262418" Y="831.1382978723371" GraphRef="dfef5" RelX="0.0" RelY="1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idd88ff05f" GroupRef="e21e5">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="2159.663865546218" Y="353.99159663865515" />
      <Point X="2209.9774067341777" Y="354.54341736694647" ArrowHead="mim-inhibition" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="iddb9af9c7">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="273.5553364254098" Y="120.61235089995893" GraphRef="ec1d5" RelX="1.0" RelY="0.5" />
      <Point X="379.8339374948402" Y="335.43723363551385" GraphRef="a81fa" RelX="-0.5" RelY="-1.0" ArrowHead="Arrow" />
      <Anchor Position="0.47052849287303833" Shape="None" GraphId="a225c" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="ide1392e42">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="1583.3333333333355" Y="48.000000000000085" GraphRef="d8449" RelX="1.0" RelY="0.0" />
      <Point X="1735.0" Y="123.28876320109016" />
      <Point X="1585.3371426801664" Y="198.57752640218024" GraphRef="b55de" RelX="1.0" RelY="0.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="ide2dd905f">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="1538.3333333333355" Y="60.500000000000085" GraphRef="d8449" RelX="0.0" RelY="1.0" />
      <Point X="1466.3333333333326" Y="112.16666666666637" GraphRef="e8ee1" RelX="0.0" RelY="-1.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="ide60b0d7">
    <Comment>VEGF-A stimulates the VEGF-A/VEGFR-2 signaling pathway</Comment>
    <Comment>ECO:0007011</Comment>
    <BiopaxRef>bb4</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1635.3546099290822" Y="1168.9716312056696" GraphRef="aad35" RelX="1.0" RelY="-0.5" />
      <Point X="1711.3333333333337" Y="1169.429964539006" GraphRef="be22f" RelX="-1.0" RelY="-0.5" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="ide65d62db">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1688.8284090557133" Y="934.7904084982472" GraphRef="d54ed" RelX="0.0" RelY="1.0" />
      <Point X="1605.354609929082" Y="985.8333333333344" GraphRef="bf587" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
      <Anchor Position="0.3199864465562985" Shape="None" GraphId="abed1" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="ide81bb95f">
    <Comment>in vitro assay evidence </Comment>
    <Comment>ECO:0000181</Comment>
    <BiopaxRef>bb0</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="789.685797547472" Y="156.10285401521548" GraphRef="cf4bb" RelX="0.0" RelY="1.0" />
      <Point X="528.4819138860712" Y="335.43723363551385" GraphRef="a81fa" RelX="0.5" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="ide9e1f962" GroupRef="e21e5">
    <Graphics ZOrder="12288" LineStyle="Broken" LineThickness="1.0">
      <Point X="2161.0745401676295" Y="296.21008403361316" />
      <Point X="2206.7548787092983" Y="296.30896098673867" ArrowHead="mim-binding" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idf4198195">
    <Comment>siRNA knockdown, Western blot for LAT phosphorylation</Comment>
    <Comment>qualitative western immunoblotting evidence</Comment>
    <Comment>ECO:0000112</Comment>
    <BiopaxRef>bf3</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1890.419474807723" Y="508.55029628162794" GraphRef="b46a5" RelX="0.0" RelY="1.0" />
      <Point X="1818.3546099290786" Y="564.3049645390029" GraphRef="e219d" RelX="0.0" RelY="-1.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idfc864e42">
    <Comment>Vav1 activation by SLP-76</Comment>
    <Comment>co-immunoprecipitation evidence and qualitative western immunoblotting evidence</Comment>
    <Comment>ECO:0000070, ECO:0000112</Comment>
    <BiopaxRef>bf3</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1943.4138233137578" Y="584.3049645390029" GraphRef="c4ee3" RelX="0.0" RelY="1.0" />
      <Point X="1888.7483723958335" Y="714.535519460444" GraphRef="fd79d" RelX="0.0" RelY="-1.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="f4652">
    <Comment>ITIM phosphorylation</Comment>
    <Comment>Mass spectometry evidence</Comment>
    <Comment>Inferred from human pbNK cells</Comment>
    <Comment>ECO:0001096</Comment>
    <BiopaxRef>cac</BiopaxRef>
    <Graphics ZOrder="32778" LineThickness="1.0">
      <Point X="1067.1326303075355" Y="456.52839976462315" GraphRef="ae538" RelX="0.5" RelY="-1.0" />
      <Point X="1243.0212765957447" Y="406.1382978723407" GraphRef="f764e" RelX="-0.5" RelY="1.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="cb53f">
    <Graphics ConnectorType="Elbow" ZOrder="32780" LineThickness="1.0">
      <Point X="1466.3333333333326" Y="137.16666666666637" GraphRef="e8ee1" RelX="0.0" RelY="1.0" />
      <Point X="1490.9471375700682" Y="165.0" />
      <Point X="1515.5609418068038" Y="185.04950602372315" GraphRef="b55de" RelX="-0.5" RelY="-1.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="f7ebc">
    <Comment>Trancriptomic data does not diffirentiate between HLA-C1 and C2 allotypes.</Comment>
    <Graphics ZOrder="32783" LineStyle="Broken" LineThickness="1.0">
      <Point X="1538.819675431258" Y="212.10554678063733" GraphRef="b55de" RelX="0.0" RelY="1.0" />
      <Point X="1832.5880662400905" Y="252.39689219572944" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="f3f50">
    <Comment>Trancriptomic data does not diffirentiate between HLA-C1 and C2 allotypes.</Comment>
    <Graphics ZOrder="32784" LineStyle="Broken" LineThickness="1.0">
      <Point X="1538.819675431258" Y="212.10554678063733" GraphRef="b55de" RelX="0.0" RelY="1.0" />
      <Point X="1269.88335810957" Y="249.40467341819345" GraphRef="a7585" RelX="0.5" RelY="-1.0" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="b5432">
    <Comment>Trancriptomic data does not diffirentiate between HLA-C1 and C2 allotypes.</Comment>
    <Graphics ZOrder="32785" LineStyle="Broken" LineThickness="1.0">
      <Point X="1538.819675431258" Y="212.10554678063733" GraphRef="b55de" RelX="0.0" RelY="1.0" />
      <Point X="1395.671035672408" Y="249.6749125741872" GraphRef="b3802" RelX="0.0" RelY="-1.0" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Label TextLabel="Low Affinity" GraphId="a2e24" GroupRef="e21e5">
    <Graphics CenterX="2096.565826330534" CenterY="295.8767507002802" Width="90.0" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle" />
  </Label>
  <Label TextLabel="Modification" GraphId="a4a19" GroupRef="e21e5">
    <Graphics CenterX="2096.5658263305313" CenterY="241.2075002119989" Width="111.66666666666606" Height="21.833333333333314" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle" />
  </Label>
  <Label TextLabel="Stimulation" GraphId="b0c48" GroupRef="e21e5">
    <Graphics CenterX="2096.565826330534" CenterY="326.5434173669468" Width="90.0" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle" />
  </Label>
  <Label TextLabel="Cell Diffirentiation" GraphId="bb4f1">
    <Graphics CenterX="761.6529292567893" CenterY="323.56756958102164" Width="139.6666666666664" Height="32.5" ZOrder="28672" FillColor="ffffff" FontSize="16" Valign="Middle" />
  </Label>
  <Label TextLabel="Derived from transcriptomics data" GraphId="c22d4">
    <Graphics CenterX="2161.848739495798" CenterY="130.2521008403361" Width="209.91596638655523" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle" />
  </Label>
  <Label TextLabel="Legend" GraphId="c3da5">
    <Graphics CenterX="2066.3333333333385" CenterY="41.66666666666666" Width="90.0" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="16" Valign="Middle" />
  </Label>
  <Label TextLabel="No Binding" GraphId="ca299">
    <Graphics CenterX="2107.7478991596636" CenterY="105.94957983193277" Width="90.0" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle" />
  </Label>
  <Label TextLabel="Ca²⁺" GraphId="dfef5" GroupRef="ae110">
    <Graphics CenterX="2210.687943262418" CenterY="818.6382978723371" Width="90.0" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle" />
  </Label>
  <Label TextLabel="RPL-Associated Signaling Protein" GraphId="e1af0">
    <Graphics CenterX="2164.4999999999977" CenterY="78.4999999999998" Width="189.00000000000455" Height="12.999999999999602" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle" />
  </Label>
  <Label TextLabel="Binding" GraphId="e438d" GroupRef="e21e5">
    <Graphics CenterX="2096.5658263305313" CenterY="178.54083863159525" Width="111.66666666666606" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle" />
  </Label>
  <Label TextLabel="Inhibition" GraphId="ecfd7" GroupRef="e21e5">
    <Graphics CenterX="2091.232492997199" CenterY="351.87675070027984" Width="90.0" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle" />
  </Label>
  <Label TextLabel="X" GraphId="f0c7c">
    <Graphics CenterX="1747.6879432624098" CenterY="323.304964539007" Width="90.0" Height="25.0" ZOrder="28672" FillColor="ff3333" FontSize="45" Valign="Middle" Color="ff3333" />
  </Label>
  <Label TextLabel="Activation" GraphId="f90b5" GroupRef="e21e5">
    <Graphics CenterX="2096.5658263305313" CenterY="207.87675070028018" Width="111.66666666666606" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle" />
  </Label>
  <Label TextLabel="Microenvironment" GraphId="fb9fd">
    <Comment></Comment>
    <Graphics CenterX="181.25056460099668" CenterY="298.0629297824405" Width="144.49409780775727" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="16" Valign="Middle" />
  </Label>
  <Label TextLabel="Catalysis" GraphId="ff295" GroupRef="e21e5">
    <Graphics CenterX="2096.5658263305313" CenterY="267.87675070028035" Width="111.66666666666606" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle" />
  </Label>
  <Label TextLabel="X" GraphId="af0af">
    <Graphics CenterX="2051.5" CenterY="106.5" Width="19.0" Height="19.0" ZOrder="32779" FillColor="ff3333" FontSize="20" Valign="Middle" Color="ff3333" />
  </Label>
  <Shape GraphId="a2eae">
    <Attribute Key="org.pathvisio.CellularComponentProperty" Value="Cell" />
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="680.0106047047291" CenterY="765.8427135340505" Width="264.0997751545797" Height="124.62731871838105" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Shape GraphId="a81fa">
    <Attribute Key="org.pathvisio.CellularComponentProperty" Value="Cell" />
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="454.1579256904558" CenterY="403.14085926789164" Width="297.2959527824621" Height="135.40725126475556" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Shape GraphId="af0c2">
    <Graphics CenterX="2142.25" CenterY="105.30462184873949" Width="249.5" Height="85.60924369747897" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Rotation="0.0" />
  </Shape>
  <Shape GraphId="b1078">
    <Attribute Key="org.pathvisio.CellularComponentProperty" Value="Cell" />
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="458.76553736919084" CenterY="96.2573017976911" Width="251.7647554806074" Height="105.05311973018553" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Shape TextLabel="Cell proliferation" GraphId="b1d91">
    <Graphics CenterX="1332.3439716312066" CenterY="1026.9999999999998" Width="233.35460992907883" Height="84.33333333333015" ZOrder="16384" FontWeight="Bold" FontSize="16" Valign="Middle" ShapeType="RoundedRectangle" Rotation="0.0" />
  </Shape>
  <Shape GraphId="b1ea3">
    <Attribute Key="org.pathvisio.CellularComponentProperty" Value="Cell" />
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="1630.343971631208" CenterY="749.8191489361703" Width="1431.312056737584" Height="714.3617021276593" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Shape TextLabel="Promotes metabolism &#xA;and &#xA;cytokine production" GraphId="bf587">
    <Graphics CenterX="1605.354609929082" CenterY="1027.9999999999995" Width="280.33333333333985" Height="84.33333333333019" ZOrder="16384" FontWeight="Bold" FontSize="16" Valign="Middle" ShapeType="RoundedRectangle" Rotation="0.0" />
  </Shape>
  <Shape GraphId="cf4bb">
    <Attribute Key="org.pathvisio.CellularComponentProperty" Value="Cell" />
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="789.685797547472" CenterY="96.91679443117943" Width="274.02670039348004" Height="118.37211916807212" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Shape GraphId="d20b9">
    <Graphics CenterX="2051.470588235294" CenterY="131.30252100840337" Width="15.0" Height="15.0" ZOrder="16384" FillColor="0000ff" FontSize="12" Valign="Middle" ShapeType="Oval" Color="0000ff" Rotation="0.0" />
  </Shape>
  <Shape TextLabel="Degranulation" GraphId="d49e4" GroupRef="e025a">
    <Graphics CenterX="1891.521276595745" CenterY="963.4716312056728" Width="163.0" Height="65.0" ZOrder="16384" FontWeight="Bold" FontSize="16" Valign="Middle" ShapeType="RoundedRectangle" Rotation="0.0" />
  </Shape>
  <Shape GraphId="dc53d" GroupRef="e21e5">
    <Graphics CenterX="2152.310924369747" CenterY="266.2815126050423" Width="210.08403361344511" Height="221.6386554621849" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Rotation="0.0" />
  </Shape>
  <Shape GraphId="e93bf">
    <Graphics CenterX="2049.499999999999" CenterY="78.0" Width="17.00000000000182" Height="14.0" ZOrder="16384" FillColor="ff6600" FontSize="12" Valign="Middle" ShapeType="Rectangle" Color="ff6600" Rotation="0.0" />
  </Shape>
  <Shape GraphId="ec1d5">
    <Attribute Key="org.pathvisio.CellularComponentProperty" Value="Cell" />
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="173.5553364254098" CenterY="95.61235089995893" Width="200.0" Height="100.0" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Shape TextLabel="Actin polymerization" GraphId="ec563" GroupRef="e025a">
    <Graphics CenterX="1890.0939716312014" CenterY="1034.666666666665" Width="217.81205673759723" Height="71.99999999999623" ZOrder="16384" FontWeight="Bold" FontSize="16" Valign="Middle" ShapeType="RoundedRectangle" Rotation="0.0" />
  </Shape>
  <Shape GraphId="f1cbb">
    <Attribute Key="org.pathvisio.CellularComponentProperty" Value="Cell" />
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="1566.0212765957447" CenterY="145.230357087553" Width="760.0" Height="242.46071417510598" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Shape GraphId="f2e67">
    <Attribute Key="org.pathvisio.CellularComponentProperty" Value="Endoplasmic Reticulum" />
    <Graphics CenterX="2157.0212765957435" CenterY="973.9716312056688" Width="129.99999999999818" Height="133.33333333334213" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="Endoplasmic Reticulum" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Group GroupId="e025a" Style="Group" />
  <Group GroupId="e21e5" Style="Group" />
  <Group GroupId="b2f4f" GraphId="add72" Style="Group" />
  <Group GroupId="e4b79" GraphId="b2f2c" Style="Group" />
  <Group GroupId="ae110" GraphId="de96c" Style="Group" />
  <Group GroupId="bcb50" GraphId="f8626" Style="Group" />
  <InfoBox CenterX="0.0" CenterY="0.0" />
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="df7">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">33335575</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Increased expression of IFN-γ in preeclampsia impairs human trophoblast invasion via a SOCS1/JAK/STAT1 feedback loop.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Exp Ther Med</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Liu H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wang W</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Liu C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">female reproductive system disease</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">DOID:229</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a00">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"> 10.1093/ humrep/del456</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">doi: 10.1093/ humrep/del456</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">21248224</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2011</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Vacca P</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Vitale C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Montaldo E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Conte R</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cantoni C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fulcheri E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Darretta V</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Moretta L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mingari MC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f4e">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">23418871</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biochemistry</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tourdot BE</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Brenner MK</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Keough KC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Holyst T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Newman PJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Newman DK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d24">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">24778445</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Maternal KIR in combination with paternal HLA-C2 regulate human birth weight.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Immunol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2014</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">38336826</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Centromeric AA motif in KIR as an optimal surrogate marker for precision definition of alloimmune reproductive failure.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sci Rep</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2024</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">38336826</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Centromeric AA motif in KIR as an optimal surrogate marker for precision definition of alloimmune reproductive failure.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sci Rep</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2024</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gil Laborda R</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">de Frías ER</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Subhi-Issa N</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">de Albornoz EC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Meliá E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Órdenes M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Verdú V</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Vidal J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Suárez E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Santillán I</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ordóñez D</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pintado-Vera D</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">González Villafáñez V</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lorenzo Á</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fariñas M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rodríguez-Paíno M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Núñez Beltrán M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">García Segovia Á</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Del Olmo A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Martín Cañadas F</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Daurelio R</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">de la Fuente A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">González Casbas JM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cabezuelo V</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ros Berruezo F</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Moreno Hidalgo MÁ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Iniesta S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bueno B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Martínez Acera Á</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Izquierdo A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Vicario JL</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fernández-Arquero M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sánchez-Ramón S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cf9">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"> DOI: 10.4049/jimmunol.166.9.5654</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">34768652</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Non-Invasive Risk Prediction Based on Right Ventricular Function in Patients with Pulmonary Arterial Hypertension.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Clin Med</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">27956621</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Expression of KIR2DS1 by decidual natural killer cells increases their ability to control placental HCMV infection.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">18192506</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Blood</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2008</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">18192506</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Blood</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2008</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">20189481</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Immunity</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kim HS</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Das A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gross CC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bryceson YT</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Long EO</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c23">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">27956621</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Expression of KIR2DS1 by decidual natural killer cells increases their ability to control placental HCMV infection.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">18322206</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Immunol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2008</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Moesta AK</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Norman PJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yawata M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yawata N</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gleimer M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Parham P</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a29">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">doi: 10.1016/ j.rbmo.2012.05.001</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">22796232</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Endometrial aspiration biopsy: a non-invasive method of obtaining functional lymphoid progenitor cells and mature natural killer cells.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Reprod Biomed Online</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">McMenamin M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lysakova-Devine T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wingfield M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">O'Herlihy C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">O'Farrelly C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bf3">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">22786724</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Complementary phosphorylation sites in the adaptor protein SLP-76 promote synergistic activation of natural killer cells.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sci Signal</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kim HS</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Long EO</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="de8">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">34267676</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">34267676</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">High Levels of Tumor Necrosis Factor-Alpha Reduce Placental Aquaporin 3 Expression and Impair in vitro Trophoblastic Cell Migration.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Front Physiol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dos Passos Junior RR</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">de Freitas RA</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Reppetti J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Medina Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dela Justina V</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bach CW</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bomfim GF</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lima VV</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Damiano AE</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Giachini FR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cac">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">29512837</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Natural killer cell cytotoxicity and its regulation by inhibitory receptors.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Immunology</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2018</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">22238634</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kinome analysis of receptor-induced phosphorylation in human natural killer cells.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PLoS One</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">König S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nimtz M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Scheiter M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ljunggren HG</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bryceson YT</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Jänsch L</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c58">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">DOI: 10.4049/jimmunol.166.9.5654</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">20189481</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Immunity</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kim HS</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Das A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gross CC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bryceson YT</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Long EO</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e25">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">29449322</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Actin retrograde flow controls natural killer cell response by regulating the conformation state of SHP-1.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">EMBO J</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2018</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Matalon O</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ben-Shmuel A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kivelevitz J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sabag B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fried S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Joseph N</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Noy E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biber G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Barda-Saad M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bb6">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10.1073/pnas.0611098104</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10.1073/pnas.0611098104</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Digitoxin metabolism by rat liver microsomes.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biochem Pharmacol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1975</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">23487420</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Conversion of peripheral blood NK cells to a decidual NK-like phenotype by a cocktail of defined factors.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Immunol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cerdeira AS</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rajakumar A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Royle CM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lo A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Husain Z</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Thadhani RI</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sukhatme VP</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Karumanchi SA</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kopcow HD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bb4">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">26327470</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Vascular Endothelial Growth Factor-A (VEGF-A) Mediates Activin A-Induced Human Trophoblast Endothelial-Like Tube Formation.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Endocrinology</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">26327470</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Vascular Endothelial Growth Factor-A (VEGF-A) Mediates Activin A-Induced Human Trophoblast Endothelial-Like Tube Formation.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Endocrinology</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Li Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zhu H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Klausen C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Peng B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Leung PC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dd8">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">24091323</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Clin Invest</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Xiong S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sharkey AM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kennedy PR</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gardner L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Farrell LE</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chazara O</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bauer J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hiby SE</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Colucci F</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Moffett A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">extravillous trophoblast</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">CL:0008036</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell Type</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f58">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">21070852</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Association of supervillin with KIR2DL1 regulates the inhibitory signaling of natural killer cells.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell Signal</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2011</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Liu HP</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yu MC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Jiang MH</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chen JX</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yan DP</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Liu F</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ge BX</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c1e">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PMC9334850</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">27956621</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Expression of KIR2DS1 by decidual natural killer cells increases their ability to control placental HCMV infection.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Crespo ÂC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Strominger JL</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tilburgs T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fb1">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">23071622</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Quantitative phosphoproteomics reveals SLP-76 dependent regulation of PAG and Src family kinases in T cells.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PLoS One</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cao L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ding Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hung N</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yu K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ritz A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Raphael BJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Salomon AR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tumor necrosis factor superfamily mediated signaling pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000236</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fc6">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">34790194</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">TNF-α Regulated Endometrial Stroma Secretome Promotes Trophoblast Invasion.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Front Immunol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">You Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Stelzl P</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Joseph DN</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Aldo PB</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Maxwell AJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dekel N</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Liao A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Whirledge S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mor G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a90">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PMC9334850.</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PMC9334850</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">5911762</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Immobilization osteoporosis. A study of the extent, severity, and treatment with bendrofluazide.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Br J Surg</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1966</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">28546555</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Immobilization osteoporosis. A study of the extent, severity, and treatment with bendrofluazide.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Br J Surg</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1966</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">28546555</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Peptide-specific engagement of the activating NK cell receptor KIR2DS1.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sci Rep</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2017</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chapel A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Garcia-Beltran WF</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hölzemer A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ziegler M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lunemann S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Martrus G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Altfeld M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a0c">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"> 24091323</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">24091323</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Clin Invest</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Xiong S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sharkey AM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kennedy PR</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gardner L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Farrell LE</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chazara O</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bauer J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hiby SE</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Colucci F</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Moffett A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d27">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">26467237</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Eur J Immunol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">34752140</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dynamic variability in SHP-1 abundance determines natural killer cell responsiveness.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sci Signal</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">34752140</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dynamic variability in SHP-1 abundance determines natural killer cell responsiveness.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sci Signal</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wu Z</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Park S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lau CM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zhong Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sheppard S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sun JC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Das J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Altan-Bonnet G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hsu KC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">altered tumor necrosis factor mediated signaling pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000618</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fb5">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">33617461</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Continuous human uterine NK cell differentiation in response to endometrial regeneration and pregnancy.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sci Immunol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Strunz B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bister J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Jönsson H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Filipovic I</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Crona-Guterstam Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kvedaraite E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sleiers N</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dumitrescu B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Brännström M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lentini A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Reinius B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cornillet M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Willinger T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gidlöf S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hamilton RS</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ivarsson MA</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Björkström NK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ea7">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">39052836</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">HLA-C expression in extravillous trophoblasts is determined by an ELF3-NLRP2/NLRP7 regulatory axis.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2024</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gu B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Le GH</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Herrera S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Blair SJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Meissner TB</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Strominger JL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fca">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"> DOI: 10.3389/fimmu.2019.01397</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">26666685</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Natural cytotoxicity receptor splice variants orchestrate the distinct functions of human natural killer cell subtypes.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nat Commun</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Siewiera J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gouilly J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hocine HR</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cartron G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Levy C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Al-Daccak R</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Jabrane-Ferrat N</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">signaling pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000003</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c8a">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PMC5206558</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">27956621</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Expression of KIR2DS1 by decidual natural killer cells increases their ability to control placental HCMV infection.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Crespo ÂC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Strominger JL</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tilburgs T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fc2">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">34016721</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Immunother Cancer</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rettman P</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Blunt MD</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fulton RJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Vallejo AF</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bastidas-Legarda LY</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">España-Serrano L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Polak ME</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Al-Shamkhani A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Retiere C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Khakoo SI</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">uterine natural killer cell</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">CL:4052028</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell Type</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f10">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10.1073/pnas.1016257108</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Digitoxin metabolism by rat liver microsomes.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biochem Pharmacol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1975</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">17208945</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cells with haematopoietic stem cell phenotype in adult human endometrium: relevance to infertility?</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hum Reprod</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2007</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lynch L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Golden-Mason L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Eogan M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">O'Herlihy C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">O'Farrelly C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bb0">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">doi: 10.4049/ jimmunol.1001637</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">20802153</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Immature NK cells, capable of producing IL-22, are present in human uterine mucosa.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Immunol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">20802153</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Immature NK cells, capable of producing IL-22, are present in human uterine mucosa.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Immunol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Male V</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hughes T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">McClory S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Colucci F</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Caligiuri MA</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Moffett A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e33">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">35561968</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Immunogenomics of Killer Cell Immunoglobulin-Like Receptor (KIR) and HLA Class I: Coevolution and Consequences for Human Health.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Allergy Clin Immunol Pract</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2022</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">27956621</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Immunogenomics of Killer Cell Immunoglobulin-Like Receptor (KIR) and HLA Class I: Coevolution and Consequences for Human Health.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Allergy Clin Immunol Pract</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2022</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">27956621</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Expression of KIR2DS1 by decidual natural killer cells increases their ability to control placental HCMV infection.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">33846431</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sci Rep</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">33846431</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sci Rep</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">33846431</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sci Rep</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">22786724</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Complementary phosphorylation sites in the adaptor protein SLP-76 promote synergistic activation of natural killer cells.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sci Signal</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">27956621</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Expression of KIR2DS1 by decidual natural killer cells increases their ability to control placental HCMV infection.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Crespo ÂC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Strominger JL</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tilburgs T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d41">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10.4049/jimmunol.1202582</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">[Structure-activity relationship of analeptics of the nicethamide type. 8. Synthesis of 2-methyl nicethamide analogs].</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Arch Pharm (Weinheim)</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1975</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">17360654</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">[Structure-activity relationship of analeptics of the nicethamide type. 8. Synthesis of 2-methyl nicethamide analogs].</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Arch Pharm (Weinheim)</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1975</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">17360654</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">[Structure-activity relationship of analeptics of the nicethamide type. 8. Synthesis of 2-methyl nicethamide analogs].</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Arch Pharm (Weinheim)</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1975</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schmoldt A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Benthe HF</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Haberland G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schmitz H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sattler HJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schunack W</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pre-natural killer cell</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">CL:0000937</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell Type</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c43">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">34392531</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cereblon regulates NK cell cytotoxicity and migration via Rac1 activation.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Eur J Immunol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2021</bp:YEAR>
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">23066148</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NK cell lytic granules are highly motile at the immunological synapse and require F-actin for post-degranulation persistence.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Immunol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mace EM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wu WW</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ho T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mann SS</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hsu HT</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Orange JS</bp:AUTHORS>
    </bp:PublicationXref>
  </Biopax>
</Pathway>

